Publications

03-28 10:04
 
Lipoprotein(a) as a cardiovascular risk factor: current status
03-28 10:04
 
Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes
03-28 10:04
 
Reducing the intensity and volume of interval training diminishes cardiovascular adaptation but not mitochondrial biogenesis in overweight/obese men
03-28 10:04
 
Effects of high-intensity interval training and moderate-intensity continuous training on endothelial function and cardiometabolic risk markers in obese adults
03-28 10:04
 
High-intensity interval training versus moderate-intensity steady-state training in UK cardiac rehabilitation programmes (HIIT or MISS UK): study protocol for a multicentre randomised controlled trial and economic evaluation
03-28 10:04
 
Physiological adaptations to low-volume, high-intensity interval training in health and disease
03-28 10:04
 
Effects of low-volume high-intensity interval training (HIT) on fitness in adults: a meta-analysis of controlled and non-controlled trials
03-28 10:04
 
Evaluating intervention fidelity: an example from a high-intensity interval training study
03-28 10:04
 
Mortality trends in the general population: the importance of cardiorespiratory fitness
03-28 10:04
 
The interaction between training and plasticity in the poststroke brain
03-28 10:04
 
Brain-computer interfaces for post-stroke motor rehabilitation: a meta-analysis
03-28 10:04
 
Contralesional Brain-Computer Interface Control of a Powered Exoskeleton for Motor Recovery in Chronic Stroke Survivors
03-28 10:04
 
Prediction of daily food intake as a function of measurement modality and restriction status
03-28 10:04
 
Sociality as a natural mechanism of public goods provision
03-28 10:04
 
Designing Interventions Informed by Scientific Knowledge About Effects of Early Adversity: A Translational Neuroscience Agenda for Next Generation Addictions Research
03-28 10:04
 
3D left ventricular extracellular volume fraction by low-radiation dose cardiac CT: assessment of interstitial myocardial fibrosis
03-28 10:04
 
Creating Effective Models for Delivering Palliative Care in Advanced Liver Disease
03-28 10:04
 
Palliative Care Always: Hepatology-Virtual Primary Palliative Care Training for Hepatologists
03-28 10:04
 
Nonhospice Palliative Care Within the Treatment of End-Stage Liver Disease
03-28 10:04
 
The effectiveness of a low-intensity problem-solving intervention for common adolescent mental health problems in New Delhi, India: protocol for a school-based, individually randomized controlled trial with an embedded stepped-wedge, cluster randomized controlled recruitment trial
03-28 10:04
 
Effectiveness of a brief lay counsellor-delivered, problem-solving intervention for adolescent mental health problems in urban, low-income schools in India: a randomised controlled trial
03-28 10:04
 
Effectiveness and costs associated with a lay counselor-delivered, brief problem-solving mental health intervention for adolescents in urban, low-income schools in India: 12-month outcomes of a randomized controlled trial
03-28 10:04
 
Correlates of Mental Illness and Wellbeing in Children: Are They the Same? Results From the UK Millennium Cohort Study
03-28 10:04
 
Internal construct validity of the Warwick-Edinburgh Mental Well-being Scale (WEMWBS): a Rasch analysis using data from the Scottish Health Education Population Survey
03-28 10:04
 
Review of the psychometric evidence of the perceived stress scale

Clinical Research News

Applying for a Paediatric investigation plan (PIP): review of the EMA guidelines
Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults

Prochains essais cliniques

Clinical Research Jobs

All jobs

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner